Literature DB >> 20661651

Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.

Sabine Pilari1, Wilhelm Huisinga.   

Abstract

In drug discovery and development, classical compartment models and physiologically based pharmacokinetic (PBPK) models are successfully used to analyze and predict the pharmacokinetics of drugs. So far, however, both approaches are used exclusively or in parallel, with little to no cross-fertilization. An approach that directly links classical compartment and PBPK models is highly desirable. We derived a new mechanistic lumping approach for reducing the complexity of PBPK models and establishing a direct link to classical compartment models. The proposed method has several advantages over existing methods: Perfusion and permeability rate limited models can be lumped; the lumped model allows for predicting the original organ concentrations; and the volume of distribution at steady state is preserved by the lumping method. To inform classical compartmental model development, we introduced the concept of a minimal lumped model that allows for prediction of the venous plasma concentration with as few compartments as possible. The minimal lumped parameter values may serve as initial values for any subsequent parameter estimation process. Applying our lumping method to 25 diverse drugs, we identified characteristic features of lumped models for moderate-to-strong bases, weak bases and acids. We observed that for acids with high protein binding, the lumped model comprised only a single compartment. The proposed lumping approach established for the first time a direct derivation of simple compartment models from PBPK models and enables a mechanistic interpretation of classical compartment models.

Mesh:

Substances:

Year:  2010        PMID: 20661651     DOI: 10.1007/s10928-010-9165-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  40 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.

Authors:  B Blanco-Serrano; M J Otero; D Santos-Buelga; M J García-Sánchez; J Serrano; A Domínguez-Gil
Journal:  Biopharm Drug Dispos       Date:  1999-07       Impact factor: 1.627

Review 3.  On the volume of distribution at steady state and its relationship with two-compartmental models.

Authors:  James W T Yates; Philip A Arundel
Journal:  J Pharm Sci       Date:  2008-01       Impact factor: 3.534

4.  Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited.

Authors:  D R Stanski; P O Maitre
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

5.  The effect of atropine on the oral absorption of lidocaine in man.

Authors:  K K Adjepon-Yamoah; D B Scott; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

6.  A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.

Authors:  Robert J Riley; D F McGinnity; R P Austin
Journal:  Drug Metab Dispos       Date:  2005-06-02       Impact factor: 3.922

7.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

8.  Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.

Authors:  K Zomorodi; A Donner; J Somma; J Barr; R Sladen; J Ramsay; E Geller; S L Shafer
Journal:  Anesthesiology       Date:  1998-12       Impact factor: 7.892

9.  A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.

Authors:  Andrea Kwa; Juraj Sprung; Michael Van Guilder; Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2008-06       Impact factor: 3.681

10.  Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

Authors:  Eleonora L Swart; Klaas P Zuideveld; Joost de Jongh; Meindert Danhof; Lambertus G Thijs; Robert M J Strack van Schijndel
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

View more
  25 in total

Review 1.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

Review 2.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope.

Authors:  María Elena Bravo-Gómez; Laura Nayeli Camacho-García; Luz Alejandra Castillo-Alanís; Miguel Ángel Mendoza-Meléndez; Alejandra Quijano-Mateos
Journal:  Toxicol Res (Camb)       Date:  2019-03-13       Impact factor: 3.524

4.  MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues.

Authors:  Silvia Maria Lavezzi; Enrica Mezzalana; Stefano Zamuner; Giuseppe De Nicolao; Peiming Ma; Monica Simeoni
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-11-10       Impact factor: 2.745

5.  Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models.

Authors:  Ludivine Fronton; Sabine Pilari; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-02-04       Impact factor: 2.745

6.  Selection and Qualification of Simplified QSP Models When Using Model Order Reduction Techniques.

Authors:  Chihiro Hasegawa; Stephen B Duffull
Journal:  AAPS J       Date:  2017-11-27       Impact factor: 4.009

7.  Understanding and reducing complex systems pharmacology models based on a novel input-response index.

Authors:  Jane Knöchel; Charlotte Kloft; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-12-14       Impact factor: 2.745

8.  Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach.

Authors:  Cécile Gérard; Jeanick Stocco; Anne Hulin; Benoit Blanchet; Céline Verstuyft; François Durand; Filomena Conti; Christophe Duvoux; Michel Tod
Journal:  AAPS J       Date:  2014-02-14       Impact factor: 4.009

9.  Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model.

Authors:  Linzhong Li; Iain Gardner; Miroslav Dostalek; Masoud Jamei
Journal:  AAPS J       Date:  2014-07-09       Impact factor: 4.009

Review 10.  Prediction of drug disposition on the basis of its chemical structure.

Authors:  David Stepensky
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.